Showing results (1421-1430 of 3,185) with videos related to

Sort By:
Pageof 319
Translational Oncology|February 28, 2024
Cell-free DNA in plasma and ascites as a biomarker of bevacizumab response- a translational research sub-study of the REZOLVE (ANZGOG-1101) clinical trialBonnita Werner, Katrin M Sjoquist, David Espinoza, et al.
Translational Oncology|February 18, 2024
Graphene therapy-related lncRNAs as prognostic and immune microenvironmental biomarkers in hepatocellular carcinomaWeilong Ye, Hui Li, Juan Zhao, et al.
Translational Oncology|February 6, 2024
Tumor-specific T cells in head and neck cancer have rescuable functionality and can be identified through single-cell co-cultureJoseph Zenga, Musaddiq Awan, Anne Frei, et al.
Translational Oncology|February 4, 2024
Distinct leukocyte populations and cytokine secretion profiles define tumoral and peritumoral areas in renal cell carcinomaMartina Borcinova, Robin Bartolini, Lily Koumbas Foley, et al.
Translational Oncology|February 3, 2024
A novel clinical nomogram for predicting cancer-specific survival in patients with non-serous epithelial ovarian cancer: A real-world analysis based on the Surveillance, Epidemiology, and End Results database and external validation in a tertiary centerHui Zheng, Jingjing Chen, Jimiao Huang, et al.
Translational Oncology|May 23, 2024
Demethylzeylasteral exerts potent efficacy against non-small-cell lung cancer via the P53 signaling pathwayLinxi Lv, Feng Zhou, Yizhou Quan, et al.
Translational Oncology|June 1, 2024
STIL facilitates the development and malignant progression of triple-negative breast cancer through activation of Fanconi anemia pathway via interacting with KLF16Meiling Wang, Bo Pan, Ye Hu, et al.
Translational Oncology|June 5, 2024
The impact of CDCA5 expression on the immune microenvironment and its potential utility as a biomarker for PD-L1/PD-1 inhibitors in lung adenocarcinomaYoung Wha Koh, Yoonjung Hwang, Seul-Ki Lee, et al.
Translational Oncology|May 14, 2024
Deubiquitinase UCHL1 stabilizes KDM4B to augment VEGF signaling and confer bevacizumab resistance in clear cell renal cell carcinomaJie Cheng, Hanqing Liu, Yan Shen, et al.
Translational Oncology|May 14, 2024
CBLC promotes the development of colorectal cancer by promoting ABI1 degradation to activate the ERK signaling pathwayZhan Li, Guanyu Yan, Meiqi Yang, et al.
Pageof 319